Download Files:
LSD1-IN-25
SKU
HY-149968-Get quote
Category Reference compound
Tags Apoptosis;Epigenetics, Apoptosis;Histone Demethylase, Cancer
Products Details
Product Description
– LSD1-IN-25 (Compound 9j) is a potent, selective and orally active LSD1 inhibitor with an IC50 of 46 nM (Ki = 30.3 nM). LSD1-IN-25 induces cancer cell apoptosis[1].
Web ID
– HY-149968
Shipping
– Room temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C32H33ClN6O3S
References
– [1]Li Z, et al. Design, synthesis and in vitro/in vivo anticancer activity of tranylcypromine-based triazolopyrimidine analogs as novel LSD1 inhibitors. Eur J Med Chem. 2023 May 5;253:115321.
CAS Number
– 2911585-60-7
Molecular Weight
– 617.16
SMILES
– ClC1=CC=CC(CN2C(N=C(SCCC)N=C3OC4=C(OC)C=C(CN[C@H]5C[C@@H]5C6=CC=CC=C6)C=C4OC)=C3N=N2)=C1
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Apoptosis;Histone Demethylase
Isoform
– KDM1/LSD1
Pathway
– Apoptosis;Epigenetics
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.